Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

GAIRDNER FOUNDATION APPOINTS CANADIAN DR. MORAG PARK AS PRESIDENT AND SCIENTIFIC DIRECTOR

Gairdner logo

News provided by

Gairdner Foundation

Jun 16, 2026, 07:04 ET

Share this article

Share toX

Share this article

Share toX

After a rigorous global search process, we are pleased to announce that a renowned cancer scientist and global research leader will succeed Dr. Janet Rossant in leading one of the world's most prestigious biomedical prize foundations.

TORONTO, June 16, 2026 /PRNewswire/ - Dr. Heather Munroe-Blum, Chair of the Gairdner Foundation Board of Directors is pleased to announce the appointment of Dr. Morag Park CQ PhD FRSC FCAHS, as its new President and Scientific Director as of June 1, 2026. Dr. Park succeeds Dr. Janet Rossant, who led the Foundation with great distinction for a decade and whose tenure concluded end of May 2026.

Dr. Park is an internationally recognized cancer researcher and scientific leader whose work has transformed the understanding of breast cancer and significantly advanced the field of precision oncology. Her pioneering research on the MET receptor, a key driver of tumour growth and metastasis, helped lay the foundation for targeted cancer therapies used around the world today. Dr. Park is a distinguished James McGill Professor and held the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University's Rosalind and Morris Goodman Cancer Institute. She is a Fellow of the Royal Society of Canada and a Knight of the Ordre national du Québec, inducted into the Canadian Medical Hall of Fame in 2026 in recognition of her accomplishments and impact.

Beyond her scientific discoveries, Dr. Park has played a leading role in shaping Canada's research ecosystem. As Scientific Director of the CIHR Institute of Cancer Research (2008–2013), she spearheaded national initiatives in personalized medicine and cancer prevention. As co-chair of the Canadian Cancer Research Alliance — comprising more than 30 funding agencies — she led the development of Canada's first Pan-Canadian Cancer Research Strategic Plan. Dr. Park has built and led research programs that have shaped the cancer research landscape in Canada and beyond.

As President and Scientific Director, Dr. Park will lead the Foundation's internationally recognized awards program and educational outreach initiatives. These advance the Foundation's role in recognizing transformative discoveries, inspiring future generations, and strengthening Canada's position as a global leader in science and innovation. Dr. Park assumes leadership at a time of growing momentum for the Foundation, as it expands its reach, partnerships, and impact both across Canada and around the world.

"The Gairdner Foundation exists to find the science that will matter most to human health, and to inspire the next generation of scientists to pursue it. That mission has never felt more urgent. I am honoured to lead an organization with this extraordinary reach and an important record of recognizing excellence before the rest of the world does."

- Dr. Morag Park, incoming President and Scientific Director, Gairdner Foundation

"I am delighted to welcome Dr. Morag Park as my successor as President and Scientific Director of the Gairdner Foundation. A distinguished scientist and inspiring leader, Morag combines exceptional vision, energy, and dedication to excellence. Under her leadership, I am confident that Gairdner will continue to strengthen its impact and reach new heights in the years ahead."

-Dr. Janet Rossant, PhD, FRS, FRSC, President & Scientific Director, Gairdner Foundation (2016-2026)

"Dr Morag Park is exactly the scientific leader to best serve the Gairdner Foundation at this moment. Her research record speaks for itself – but it is her rigorous standards and her ability to support scientists and build the systems that allow great science to flourish, that make her appointment so very exciting."

-Dr. Heather Munroe-Blum PhD, OC, OQ, FRSC, Chair, Gairdner Foundation

"The appointment of Dr. Park, an exemplary science leader and scientist, assures the continued recognition of excellence by the Canada Gairdner Awards."

-Dr. Philip Sharp, Institute Professor and Professor of Biology Emeritus; Intramural Faculty, Koch Institute, MIT, Canada Gairdner International Award (1986), Nobel Prize, Physiology or Medicine (1993)

About the Gairdner Foundation

The Gairdner Foundation is a Canadian non-profit organization dedicated to recognizing and celebrating international excellence in biomedical research and global health. Established in 1957, the Gairdner Foundation is among the world's most distinguished biomedical research prize organizations. Since its founding, 443 awards have been bestowed on scientists from more than 40 countries. 103 Canada Gairdner International Award laureates have gone on to receive Nobel Prizes.

About Morag Park

Morag Park received a BSc with first class honours from the University of Glasgow, a PhD at the Medical Research Council Virology Institute in Scotland and completed postdoctoral training at the National Institutes for Cancer Research in Washington DC. She is a recipient of a Canadian Cancer Research Alliance Award (2015) for Exceptional Leadership in Cancer Research, the Canadian Cancer Society Robert L. Noble Prize (2017), the Quebec Breast Cancer Foundation Grand Prix Scientifique (2019), and the Club de Recherches Cliniques du Québec Michel Sarrazin Award (2021).

SOURCE Gairdner Foundation

21%

more press release views with 
Request a Demo

Modal title

Also from this source

2026 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-LEADING SCIENTISTS FOR BREAKTHROUGH DISCOVERIES ADVANCING HUMAN HEALTH

2026 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-LEADING SCIENTISTS FOR BREAKTHROUGH DISCOVERIES ADVANCING HUMAN HEALTH

Prestigious international award recognizes landmark discoveries in biomedical and global health research. TORONTO, March 31, 2026 /PRNewswire/ - The...

GAIRDNER SCIENCE WEEK BRINGS GLOBAL SCIENTIFIC EXPERTS TO CANADA TO CELEBRATE RESEARCH IMPACTING HUMAN HEALTH

GAIRDNER SCIENCE WEEK BRINGS GLOBAL SCIENTIFIC EXPERTS TO CANADA TO CELEBRATE RESEARCH IMPACTING HUMAN HEALTH

Canada's premier celebration of scientific discovery returns October 20-23, spotlighting research that's transforming global health and the future of ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Personnel Announcements

Personnel Announcements

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.